Pharmacogenomics: driving personalized medicine

W Sadee, D Wang, K Hartmann, AE Toland - Pharmacological reviews, 2023 - ASPET
Personalized medicine tailors therapies, disease prevention, and health maintenance to the
individual, with pharmacogenomics serving as a key tool to improve outcomes and prevent …

Insecticide resistance in mosquitoes: impact, mechanisms, and research directions

N Liu - Annual review of entomology, 2015 - annualreviews.org
Mosquito-borne diseases, the most well known of which is malaria, are among the leading
causes of human deaths worldwide. Vector control is a very important part of the global …

Synonymous but not the same: the causes and consequences of codon bias

JB Plotkin, G Kudla - Nature Reviews Genetics, 2011 - nature.com
Despite their name, synonymous mutations have significant consequences for cellular
processes in all taxa. As a result, an understanding of codon bias is central to fields as …

Pharmacogenetics of direct oral anticoagulants: a systematic review

J Raymond, L Imbert, T Cousin, T Duflot… - Journal of Personalized …, 2021 - mdpi.com
Dabigatran, rivaroxaban, apixaban, edoxaban, and betrixaban are direct oral anticoagulants
(DOACs). Their inter-individual variability in pharmacodynamics and pharmacokinetics …

A "Silent" Polymorphism in the MDR1 Gene Changes Substrate Specificity

C Kimchi-Sarfaty, JM Oh, IW Kim, ZE Sauna… - Science, 2007 - science.org
Synonymous single-nucleotide polymorphisms (SNPs) do not produce altered coding
sequences, and therefore they are not expected to change the function of the protein in …

Very important pharmacogene summary

LM Hodges, SM Markova, LW Chinn… - Pharmacogenetics …, 2011 - journals.lww.com
ABCB1 (MDR1) is one of many ubiquitous adenosine triphosphate (ATP)-binding cassette
(ABC) genes present in all kingdoms of life that is responsible for cellular homeostasis [1–3] …

Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature

S Wolking, E Schaeffeler, H Lerche, M Schwab… - Clinical …, 2015 - Springer
ATP-binding cassette transporter B1 (ABCB1; P-glycoprotein; multidrug resistance protein 1)
is an adenosine triphosphate (ATP)-dependent efflux transporter located in the plasma …

Perplexing role of P-glycoprotein in tumor microenvironment

K Robinson, V Tiriveedhi - Frontiers in oncology, 2020 - frontiersin.org
Development of multidrug resistance (MDR) still remains a major obstacle to the long-term
success of cancer therapy. P-glycoprotein (P-gp) is a well-identified membrane transporter …

Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs

D Wang, Y Guo, SA Wrighton, GE Cooke… - The pharmacogenomics …, 2011 - nature.com
Abstract Cytochrome P450 3A4 (CYP3A4) metabolizes∼ 50% of all clinically used drugs.
Although CYP3A4 expression varies widely between individuals, the contribution of genetic …

Common Sequence Variants in the LOXL1 Gene Confer Susceptibility to Exfoliation Glaucoma

G Thorleifsson, KP Magnusson, P Sulem, GB Walters… - Science, 2007 - science.org
Glaucoma is a leading cause of irreversible blindness. A genome-wide search yielded
multiple single-nucleotide polymorphisms (SNPs) in the 15q24. 1 region associated with …